Evidence map›Paper›PMID 23842494›Full record

ArticleNature2013

Characterization of H7N9 influenza A viruses isolated from humans.

Tokiko Watanabe, Maki Kiso, Satoshi Fukuyama, Noriko Nakajima, Masaki Imai, Shinya Yamada, Shin Murakami, Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Yoshihiro Sakoda and 40 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 256 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
256citing papers in PubMed, 1 pooled it
45.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

256 citing papers in PubMed, 1 synthesis or guideline pooled it, 403 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Understanding and controlling pandemic influenza.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Viral factors underlying the pandemic potential of influenza viruses.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  14. Article
  15. PA and PA-X: two key proteins from segment 3 of the influenza viruses.Frontiers in cellular and infection microbiology · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

196 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors at 9 institutions in 3 countries.

Tokiko WatanabeERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama 332-0012, Japan.
Maki Kiso
Satoshi Fukuyama
Noriko Nakajima
Masaki Imai
Shinya Yamada
Shin Murakami
Seiya Yamayoshi
Kiyoko Iwatsuki-Horimoto
Yoshihiro Sakoda
Emi Takashita
Ryan McBride
Takeshi Noda
Masato Hatta
Hirotaka Imai
Dongming Zhao
Noriko Kishida
Masayuki Shirakura
Robert P de Vries
Shintaro Shichinohe
Masatoshi Okamatsu
Tomokazu Tamura
Yuriko Tomita
Naomi Fujimoto
Kazue Goto
Hiroaki Katsura
Eiryo Kawakami
Izumi Ishikawa
Shinji Watanabe
Mutsumi Ito
Yuko Sakai-Tagawa
Yukihiko Sugita
Ryuta Uraki
Reina Yamaji
Amie J Eisfeld
Gongxun Zhong
Shufang Fan
Jihui Ping
Eileen A Maher
Anthony Hanson
Yuko Uchida
Takehiko Saito
Makoto Ozawa
Gabriele Neumann
Hiroshi Kida
Takato Odagiri
James C Paulson
Hideki Hasegawa
Masato Tashiro
Yoshihiro Kawaoka
Japan Science and Technology Agency · JPNational Institute of Infectious Diseases · JPUniversity of Wisconsin–Madison · USThe University of Tokyo · JPHokkaido University · JPTokyo University of Science · JPScripps Research Institute · USNational Institute of Animal Health · JPKagoshima University · JP

Funding

Viral and Host cDNA Libraries from 1918 Influenza CasesP01AI058113 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GARCIA-SASTRE, ADOLFO · 2004 to 2010
$20.3M
Virology Training ProgramT32AI078985 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F. · 2009 to 2018
$3.3M
NIAID NIH HHS AI058113NIAID NIH HHS AI099274NIAID NIH HHS HHSN266200700010CNIAID NIH HHS P01 AI058113NIAID NIH HHS T32 AI078985
6 · The paper itself

Abstract

Avian influenza A viruses rarely infect humans; however, when human infection and subsequent human-to-human transmission occurs, worldwide outbreaks (pandemics) can result. The recent sporadic infections of humans in China with a previously unrecognized avian influenza A virus of the H7N9 subtype (A(H7N9)) have caused concern owing to the appreciable case fatality rate associated with these infections (more than 25%), potential instances of human-to-human transmission, and the lack of pre-existing immunity among humans to viruses of this subtype. Here we characterize two early human A(H7N9) isolates, A/Anhui/1/2013 (H7N9) and A/Shanghai/1/2013 (H7N9); hereafter referred to as Anhui/1 and Shanghai/1, respectively. In mice, Anhui/1 and Shanghai/1 were more pathogenic than a control avian H7N9 virus (A/duck/Gunma/466/2011 (H7N9); Dk/GM466) and a representative pandemic 2009 H1N1 virus (A/California/4/2009 (H1N1pdm09); CA04). Anhui/1, Shanghai/1 and Dk/GM466 replicated well in the nasal turbinates of ferrets. In nonhuman primates, Anhui/1 and Dk/GM466 replicated efficiently in the upper and lower respiratory tracts, whereas the replicative ability of conventional human influenza viruses is typically restricted to the upper respiratory tract of infected primates. By contrast, Anhui/1 did not replicate well in miniature pigs after intranasal inoculation. Critically, Anhui/1 transmitted through respiratory droplets in one of three pairs of ferrets. Glycan arrays showed that Anhui/1, Shanghai/1 and A/Hangzhou/1/2013 (H7N9) (a third human A(H7N9) virus tested in this assay) bind to human virus-type receptors, a property that may be critical for virus transmissibility in ferrets. Anhui/1 was found to be less sensitive in mice to neuraminidase inhibitors than a pandemic H1N1 2009 virus, although both viruses were equally susceptible to an experimental antiviral polymerase inhibitor. The robust replicative ability in mice, ferrets and nonhuman primates and the limited transmissibility in ferrets of Anhui/1 suggest that A(H7N9) viruses have pandemic potential.

Indexed as

Influenza A virusVirus ReplicationAnimalsAntiviral AgentsCells, CulturedChickensDNA-Directed RNA PolymerasesDogsEnzyme InhibitorsFemaleFerretsHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanMacaca fascicularisMadin Darby Canine Kidney CellsAntiviral AgentsDNA-Directed RNA PolymerasesEnzyme InhibitorsNeuraminidase

Identifiers

PMID23842494
PMCPMC3891892
OpenAlexW2005855529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.